pyridoxamine has been researched along with malondialdehyde in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kang, Z; Li, G; Li, H; Yin, D | 1 |
Gohda, T; Hagiwara, S; Horikoshi, S; Ishikawa, Y; Murakoshi, M; Ohara, I; Tanimoto, M; Tomino, Y; Toyoda, H | 1 |
Funabiki, K; Gohda, T; Hagiwara, S; Horikoshi, S; Ito, T; Matsumoto, M; Murakoshi, M; Ohara, I; Tanimoto, M; Tomino, Y; Yamazaki, T | 1 |
Deng, Z; Lin, F; Lin, H; Sun, C; Yu, H; Zhou, C; Zhu, P; Zhuo, X | 1 |
Bidasee, KR; Kutty, S; Moore, CJ; Nagai, R; Shao, CH; Singh, J | 1 |
Hu, X; Tao, N; Wang, M; Wang, X; Wong, D | 1 |
Aldini, G; Carini, M; Casali, G; Colzani, M; De Maddis, D; Vistoli, G | 1 |
7 other study(ies) available for pyridoxamine and malondialdehyde
Article | Year |
---|---|
Reaction of pyridoxamine with malondialdehyde: mechanism of inhibition of formation of advanced lipoxidation end-products.
Topics: Animals; Chromatography, High Pressure Liquid; Glycation End Products, Advanced; Humans; In Vitro Techniques; Lipid Peroxidation; Malondialdehyde; Models, Biological; Molecular Structure; Pyridoxamine; Spectrometry, Mass, Electrospray Ionization | 2006 |
Pleiotropic effect of pyridoxamine on diabetic complications via CD36 expression in KK-Ay/Ta mice.
Topics: Adipose Tissue; Animals; CD36 Antigens; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Evaluation, Preclinical; Gene Expression Regulation; Hypoglycemic Agents; Insulin Resistance; Kidney; Lipid Peroxidation; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Pyridoxamine | 2009 |
Effects of pyridoxamine (K-163) on glucose intolerance and obesity in high-fat diet C57BL/6J mice.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adipokines; Adipose Tissue; Animals; Antioxidants; Cholesterol; Deoxyguanosine; Dietary Fats; Glucose Intolerance; Glycation End Products, Advanced; Hydrogen Peroxide; Immunohistochemistry; Malondialdehyde; Mice; Mice, Inbred C57BL; Muscle, Skeletal; NADPH Oxidases; Obesity; Pyridoxamine; Random Allocation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Superoxide Dismutase; Triglycerides | 2009 |
Synergistic effects of telmisartan and pyridoxamine on early renal damage in spontaneously hypertensive rats.
Topics: Animals; Benzimidazoles; Benzoates; Drug Synergism; Glycation End Products, Advanced; Kidney; Male; Malondialdehyde; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Protective Agents; Pyridoxamine; Rats; Rats, Inbred SHR; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Superoxide Dismutase; Telmisartan; Transcription Factor RelA; Transforming Growth Factor beta | 2012 |
Malondialdehyde and 4-hydroxynonenal adducts are not formed on cardiac ryanodine receptor (RyR2) and sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA2) in diabetes.
Topics: Aldehydes; Animals; Arginine; Calcium; Cyclic N-Oxides; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Echocardiography; Guanidines; Lysine; Male; Malondialdehyde; Myocytes, Cardiac; Norleucine; Protein Carbonylation; Pyridoxamine; Pyrroles; Rats; Rats, Sprague-Dawley; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Spin Labels | 2013 |
Effect and mechanism of pyridoxamine on the lipid peroxidation and stability of polyunsaturated fatty acids in beef patties.
Topics: alpha-Tocopherol; Animals; Ascorbic Acid; Cattle; Drug Stability; Fatty Acids, Unsaturated; Lipid Peroxidation; Malondialdehyde; Pyridoxamine; Pyridoxine; Red Meat; Thiobarbiturates; Tretinoin; Vitamins | 2016 |
Reactivity, Selectivity, and Reaction Mechanisms of Aminoguanidine, Hydralazine, Pyridoxamine, and Carnosine as Sequestering Agents of Reactive Carbonyl Species: A Comparative Study.
Topics: Aldehydes; Carnosine; Dose-Response Relationship, Drug; Glyoxal; Guanidines; Humans; Hydralazine; Malondialdehyde; Molecular Structure; Pyridoxamine; Pyruvaldehyde; Sequestering Agents; Structure-Activity Relationship | 2016 |